Meeting
2023 ASCO Quality Care Symposium
Utilizing a best practice advisory (BPA) to increase pneumocystis jirovecii pneumonia (PJP) prophylaxis prescribing for patients with cancer on high dose corticosteroids.
Authors
Megan Spradlin
The University of Colorado, Aurora, CO
Megan Spradlin, Sarah Rhoads, James Maloney, Brian Montague, Abraham Wick, Li-Kheng Ngov, Sarah Samaya Norskog, Kasey Bowden, Laura Graham
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Survivorship
Sub Track
Patient Safety
Citation
JCO Oncol Pract 19, 2023 (suppl 11; abstr 391)
DOI
10.1200/OP.2023.19.11_suppl.391
Abstract #
391
Poster Bd #
H1
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Quality Care Symposium
Treatment, mortality, and health care costs in a U.S. cohort of indolent non-Hodgkin lymphoma patients with relapsed or refractory disease.
First Author: Nicole Meyer
Poster
2024 ASCO Annual Meeting
Real-world risk of bleeding events in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) treated with BTKi.
First Author: Javid J. Moslehi
Poster
2024 ASCO Annual Meeting
Extended follow-up results beyond 2.5 years from the pivotal NHL-1 EPCORE trial: Subcutaneous epcoritamab monotherapy in patients with relapsed/refractory large B-cell lymphoma (R/R LBCL).
First Author: Yasmin Karimi
Poster
2024 ASCO Genitourinary Cancers Symposium
Risk of early non-cancer deaths in adults diagnosed with metastatic genitourinary (mGU) cancers: A retrospective cohort study.
First Author: Ahsan Ayaz